Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 260

1.

Early focality and spread of cortical dysfunction in amyotrophic lateral sclerosis: A regional study across the motor cortices.

Dharmadasa T, Matamala JM, Howells J, Vucic S, Kiernan MC.

Clin Neurophysiol. 2019 Dec 23. pii: S1388-2457(19)31361-6. doi: 10.1016/j.clinph.2019.11.057. [Epub ahead of print]

PMID:
31959568
2.

Clinical and therapeutic predictors of disease outcomes in AQP4-IgG+ neuromyelitis optica spectrum disorder.

Kunchok A, Malpas C, Nytrova P, Havrdova EK, Alroughani R, Terzi M, Yamout B, Hor JY, Karabudak R, Boz C, Ozakbas S, Olascoaga J, Simo M, Granella F, Patti F, McCombe P, Csepany T, Singhal B, Bergamaschi R, Fragoso Y, Al-Harbi T, Turkoglu R, Lechner-Scott J, Laureys G, Oreja-Guevara C, Pucci E, Sola P, Ferraro D, Altintas A, Soysal A, Vucic S, Grand'Maison F, Izquierdo G, Eichau S, Lugaresi A, Onofrj M, Trojano M, Marriott M, Butzkueven H, Kister I, Kalincik T.

Mult Scler Relat Disord. 2019 Nov 25;38:101868. doi: 10.1016/j.msard.2019.101868. [Epub ahead of print]

PMID:
31877445
3.

Inherited Neuropathies.

Carroll AS, Burns J, Nicholson G, Kiernan MC, Vucic S.

Semin Neurol. 2019 Oct;39(5):620-639. doi: 10.1055/s-0039-1693006. Epub 2019 Oct 22.

PMID:
31639845
4.

"Taming the Beast": Exploring the Lived Experience of Relapsing Remitting Multiple Sclerosis Using a Life History Approach.

Burke T, Vucic S, Patching J.

Res Theory Nurs Pract. 2019 Aug 1;33(3):229-245. doi: 10.1891/1541-6577.33.3.229.

PMID:
31615943
5.

Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination.

Tea F, Lopez JA, Ramanathan S, Merheb V, Lee FXZ, Zou A, Pilli D, Patrick E, van der Walt A, Monif M, Tantsis EM, Yiu EM, Vucic S, Henderson APD, Fok A, Fraser CL, Lechner-Scott J, Reddel SW, Broadley S, Barnett MH, Brown DA, Lunemann JD, Dale RC, Brilot F; Australasian and New Zealand MOG Study Group.

Acta Neuropathol Commun. 2019 Sep 3;7(1):145. doi: 10.1186/s40478-019-0786-3.

6.

Measurement of axonal excitability: Consensus guidelines.

Kiernan MC, Bostock H, Park SB, Kaji R, Krarup C, Krishnan AV, Kuwabara S, Lin CS, Misawa S, Moldovan M, Sung J, Vucic S, Wainger BJ, Waxman S, Burke D.

Clin Neurophysiol. 2020 Jan;131(1):308-323. doi: 10.1016/j.clinph.2019.07.023. Epub 2019 Aug 2. Review.

7.

Regional motor cortex dysfunction in amyotrophic lateral sclerosis.

Menon P, Yiannikas C, Kiernan MC, Vucic S.

Ann Clin Transl Neurol. 2019 Aug;6(8):1373-1382. doi: 10.1002/acn3.50819. Epub 2019 Jun 28.

8.

Risk of secondary progressive multiple sclerosis: A longitudinal study.

Fambiatos A, Jokubaitis V, Horakova D, Kubala Havrdova E, Trojano M, Prat A, Girard M, Duquette P, Lugaresi A, Izquierdo G, Grand'Maison F, Grammond P, Sola P, Ferraro D, Alroughani R, Terzi M, Hupperts R, Boz C, Lechner-Scott J, Pucci E, Bergamaschi R, Van Pesch V, Ozakbas S, Granella F, Turkoglu R, Iuliano G, Spitaleri D, McCombe P, Solaro C, Slee M, Ampapa R, Soysal A, Petersen T, Sanchez-Menoyo JL, Verheul F, Prevost J, Sidhom Y, Van Wijmeersch B, Vucic S, Cristiano E, Saladino ML, Deri N, Barnett M, Olascoaga J, Moore F, Skibina O, Gray O, Fragoso Y, Yamout B, Shaw C, Singhal B, Shuey N, Hodgkinson S, Altintas A, Al-Harbi T, Csepany T, Taylor B, Hughes J, Jun JK, van der Walt A, Spelman T, Butzkueven H, Kalincik T.

Mult Scler. 2020 Jan;26(1):79-90. doi: 10.1177/1352458519868990. Epub 2019 Aug 9.

PMID:
31397221
9.

Dental development and craniofacial morphology in school-age children.

Vucic S, Dhamo B, Jaddoe VWV, Wolvius EB, Ongkosuwito EM.

Am J Orthod Dentofacial Orthop. 2019 Aug;156(2):229-237.e4. doi: 10.1016/j.ajodo.2018.09.014.

PMID:
31375233
10.

Is Motor Unit Number Index (MUNIX) an index of Compound Muscle Action Potential amplitude rather than motor unit number?

Moldovan M, Vucic S.

Clin Neurophysiol. 2019 Sep;130(9):1686-1687. doi: 10.1016/j.clinph.2019.06.010. Epub 2019 Jul 4. No abstract available.

PMID:
31303432
11.

Motor neuron disease with malignancy: Clinical and pathophysiological insights.

Higashihara M, Menon P, Geevasinga N, Van den Bos MAJ, Kiernan MC, Vucic S.

Clin Neurophysiol. 2019 Sep;130(9):1557-1561. doi: 10.1016/j.clinph.2019.05.026. Epub 2019 Jun 22.

PMID:
31301633
12.

Safety and tolerability of Triumeq in amyotrophic lateral sclerosis: the Lighthouse trial.

Gold J, Rowe DB, Kiernan MC, Vucic S, Mathers S, van Eijk RPA, Nath A, Garcia Montojo M, Norato G, Santamaria UA, Rogers ML, Malaspina A, Lombardi V, Mehta PR, Westeneng HJ, van den Berg LH, Al-Chalabi A.

Amyotroph Lateral Scler Frontotemporal Degener. 2019 Nov;20(7-8):595-604. doi: 10.1080/21678421.2019.1632899. Epub 2019 Jul 8.

PMID:
31284774
13.

Amyotrophic lateral sclerosis as a multi-step process: an Australia population study.

Vucic S, Westeneng HJ, Al-Chalabi A, Van Den Berg LH, Talman P, Kiernan MC.

Amyotroph Lateral Scler Frontotemporal Degener. 2019 Nov;20(7-8):532-537. doi: 10.1080/21678421.2018.1556697. Epub 2019 Jul 8.

PMID:
31284763
14.

Pathophysiology and Diagnosis of ALS: Insights from Advances in Neurophysiological Techniques.

van den Bos MAJ, Geevasinga N, Higashihara M, Menon P, Vucic S.

Int J Mol Sci. 2019 Jun 10;20(11). pii: E2818. doi: 10.3390/ijms20112818. Review.

15.

Immune checkpoint inhibitors and neuropathy: A new dawn.

Vucic S.

Clin Neurophysiol. 2019 Aug;130(8):1401-1402. doi: 10.1016/j.clinph.2019.05.004. Epub 2019 May 9. No abstract available.

PMID:
31101419
16.

Split elbow sign: more evidence for the importance of cortical dysfunction in ALS.

Vucic S.

J Neurol Neurosurg Psychiatry. 2019 Jul;90(7):729. doi: 10.1136/jnnp-2019-320534. Epub 2019 Mar 25. No abstract available.

PMID:
30910859
17.

Conduction block in immune-mediated neuropathy: paranodopathy versus axonopathy.

Garg N, Park SB, Howells J, Vucic S, Yiannikas C, Mathey EK, Nguyen T, Noto Y, Barnett MH, Krishnan AV, Spies J, Bostock H, Pollard JD, Kiernan MC.

Eur J Neurol. 2019 Aug;26(8):1121-1129. doi: 10.1111/ene.13953. Epub 2019 Apr 26.

PMID:
30882969
18.

The effect of coil type and limb dominance in the assessment of lower-limb motor cortex excitability using TMS.

Dharmadasa T, Matamala JM, Howells J, Simon NG, Vucic S, Kiernan MC.

Neurosci Lett. 2019 Apr 23;699:84-90. doi: 10.1016/j.neulet.2019.01.050. Epub 2019 Jan 30.

PMID:
30710665
19.

Amyotrophic lateral sclerosis diagnostic index: Toward a personalized diagnosis of ALS.

Geevasinga N, Howells J, Menon P, van den Bos M, Shibuya K, Matamala JM, Park SB, Byth K, Kiernan MC, Vucic S.

Neurology. 2019 Feb 5;92(6):e536-e547. doi: 10.1212/WNL.0000000000006876. Epub 2019 Jan 11.

PMID:
30709964
20.

Core temperature is not elevated at rest in people with relapsing-remitting multiple sclerosis.

Chaseling GK, Allen DR, Vucic S, Barnett M, Frohman E, Davis SL, Jay O.

Mult Scler Relat Disord. 2019 Apr;29:62-67. doi: 10.1016/j.msard.2019.01.013. Epub 2019 Jan 4.

PMID:
30684887
21.

Functional Biomarkers for Amyotrophic Lateral Sclerosis.

Huynh W, Dharmadasa T, Vucic S, Kiernan MC.

Front Neurol. 2019 Jan 4;9:1141. doi: 10.3389/fneur.2018.01141. eCollection 2018. Review.

22.

Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis.

Kalincik T, Kubala Havrdova E, Horakova D, Izquierdo G, Prat A, Girard M, Duquette P, Grammond P, Onofrj M, Lugaresi A, Ozakbas S, Kappos L, Kuhle J, Terzi M, Lechner-Scott J, Boz C, Grand'Maison F, Prevost J, Sola P, Ferraro D, Granella F, Trojano M, Bergamaschi R, Pucci E, Turkoglu R, McCombe PA, Pesch VV, Van Wijmeersch B, Solaro C, Ramo-Tello C, Slee M, Alroughani R, Yamout B, Shaygannejad V, Spitaleri D, Sánchez-Menoyo JL, Ampapa R, Hodgkinson S, Karabudak R, Butler E, Vucic S, Jokubaitis V, Spelman T, Butzkueven H.

J Neurol Neurosurg Psychiatry. 2019 Apr;90(4):458-468. doi: 10.1136/jnnp-2018-319831. Epub 2019 Jan 13.

PMID:
30636699
23.

Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: A contemporary cohort study.

Nguyen AL, Havrdova EK, Horakova D, Izquierdo G, Kalincik T, van der Walt A, Terzi M, Alroughani R, Duquette P, Girard M, Prat A, Boz C, Sola P, Ferraro D, Lugaresi A, Lechner-Scott J, Barnett M, Grand'Maison F, Grammond P, Ramo-Tello C, Turkoglu R, McCombe P, Pucci E, Trojano M, Granella F, Spitaleri D, Van Pesch V, Soysal A, Oreja-Guevara C, Verheul F, Vucic S, Hodgkinson S, Slee M, Ampapa R, Prevost J, Menoyo JLS, Skibina O, Solaro C, Olascoaga J, Shaw C, Madsen KG, Naidoo K, Hyde R, Butzkueven H, Jokubaitis V; MSBase Study Group.

Mult Scler Relat Disord. 2019 Feb;28:235-243. doi: 10.1016/j.msard.2019.01.003. Epub 2019 Jan 3.

PMID:
30623864
24.

Utility of threshold tracking transcranial magnetic stimulation in ALS.

Vucic S, van den Bos M, Menon P, Howells J, Dharmadasa T, Kiernan MC.

Clin Neurophysiol Pract. 2018 Nov 17;3:164-172. doi: 10.1016/j.cnp.2018.10.002. eCollection 2018. Review.

25.

Efficacy and safety of teriflunomide in Asian patients with relapsing forms of multiple sclerosis: A subgroup analysis of the phase 3 TOWER study.

Miller AE, Xu X, Macdonell R, Vucic S, Truffinet P, Benamor M, Thangavelu K, Freedman MS.

J Clin Neurosci. 2019 Jan;59:229-231. doi: 10.1016/j.jocn.2018.09.012. Epub 2018 Oct 20.

26.

Imbalance of cortical facilitatory and inhibitory circuits underlies hyperexcitability in ALS.

Van den Bos MAJ, Higashihara M, Geevasinga N, Menon P, Kiernan MC, Vucic S.

Neurology. 2018 Oct 30;91(18):e1669-e1676. doi: 10.1212/WNL.0000000000006438. Epub 2018 Oct 3.

PMID:
30282772
27.

Miller Fisher Syndrome Associated With Immunotherapy for Metastatic Melanoma.

Baird-Gunning JJD, Weerasinghe D, Silsby M, Gawarikar Y, Carlino MS, Smith JL, Vucic S.

Neurohospitalist. 2018 Oct;8(4):191-193. doi: 10.1177/1941874418778957. Epub 2018 May 27.

28.

Silent lesions on MRI imaging - Shifting goal posts for treatment decisions in multiple sclerosis.

Min M, Spelman T, Lugaresi A, Boz C, Spitaleri D, Pucci E, Grand'Maison F, Granella F, Izquierdo G, Butzkueven H, Sanchez-Menoyo JL, Barnett M, Girard M, Trojano M, Grammond P, Duquette P, Sola P, Alroughani R, Hupperts R, Vucic S, Kalincik T, Van Pesch V, Lechner-Scott J.

Mult Scler. 2018 Oct;24(12):1569-1577. doi: 10.1177/1352458518798147. Epub 2018 Sep 20.

PMID:
30234431
29.

Differences in inflammatory profiles between ALS and FTD.

Vucic S.

J Neurol Neurosurg Psychiatry. 2019 Jan;90(1):1. doi: 10.1136/jnnp-2018-319377. Epub 2018 Sep 17. No abstract available.

PMID:
30224547
30.

Reproducibility of motor unit number index and multiple point stimulation motor unit number estimation in controls.

Higashihara M, Menon P, van den Bos M, Geevasinga N, Vucic S.

Muscle Nerve. 2018 Nov;58(5):660-664. doi: 10.1002/mus.26339. Epub 2018 Oct 15.

PMID:
30194855
31.

Patients' perspectives of multidisciplinary home-based e-Health service delivery for motor neurone disease.

James N, Power E, Hogden A, Vucic S.

Disabil Rehabil Assist Technol. 2019 Oct;14(7):737-743. doi: 10.1080/17483107.2018.1499139. Epub 2018 Sep 5.

PMID:
30182780
32.

In vivo evidence for reduced ion channel expression in motor axons of patients with amyotrophic lateral sclerosis.

Howells J, Matamala JM, Park SB, Garg N, Vucic S, Bostock H, Burke D, Kiernan MC.

J Physiol. 2018 Nov;596(22):5379-5396. doi: 10.1113/JP276624. Epub 2018 Oct 17.

33.

Anti-MAG neuropathy: Role of IgM antibodies, the paranodal junction and juxtaparanodal potassium channels.

Garg N, Park SB, Howells J, Noto YI, Vucic S, Yiannikas C, Tomlinson SE, Huynh W, Simon NG, Mathey EK, Spies J, Pollard JD, Krishnan AV, Kiernan MC.

Clin Neurophysiol. 2018 Oct;129(10):2162-2169. doi: 10.1016/j.clinph.2018.07.021. Epub 2018 Aug 10.

PMID:
30144659
34.

Fasciculation intensity and disease progression in amyotrophic lateral sclerosis.

Tsugawa J, Dharmadasa T, Ma Y, Huynh W, Vucic S, Kiernan MC.

Clin Neurophysiol. 2018 Oct;129(10):2149-2154. doi: 10.1016/j.clinph.2018.07.015. Epub 2018 Aug 2.

PMID:
30114663
35.

Neurophysiological biomarkers in amyotrophic lateral sclerosis.

Vucic S, Rutkove SB.

Curr Opin Neurol. 2018 Oct;31(5):640-647. doi: 10.1097/WCO.0000000000000593. Review.

PMID:
30080715
36.

Comparison of cross-sectional areas and distal-proximal nerve ratios in amyotrophic lateral sclerosis.

Noto YI, Garg N, Li T, Timmins HC, Park SB, Shibuya K, Shahrizaila N, Huynh W, Matamala JM, Dharmadasa T, Yiannikas C, Vucic S, Kiernan MC.

Muscle Nerve. 2018 Dec;58(6):777-783. doi: 10.1002/mus.26301. Epub 2018 Oct 15.

PMID:
30019401
37.

Cortical excitability varies across different muscles.

Menon P, Kiernan MC, Vucic S.

J Neurophysiol. 2018 Sep 1;120(3):1397-1403. doi: 10.1152/jn.00148.2018. Epub 2018 Jul 5.

38.

Consortium-based genome-wide meta-analysis for childhood dental caries traits.

Haworth S, Shungin D, van der Tas JT, Vucic S, Medina-Gomez C, Yakimov V, Feenstra B, Shaffer JR, Lee MK, Standl M, Thiering E, Wang C, Bønnelykke K, Waage J, Jessen LE, Nørrisgaard PE, Joro R, Seppälä I, Raitakari O, Dudding T, Grgic O, Ongkosuwito E, Vierola A, Eloranta AM, West NX, Thomas SJ, McNeil DW, Levy SM, Slayton R, Nohr EA, Lehtimäki T, Lakka T, Bisgaard H, Pennell C, Kühnisch J, Marazita ML, Melbye M, Geller F, Rivadeneira F, Wolvius EB, Franks PW, Johansson I, Timpson NJ.

Hum Mol Genet. 2018 Sep 1;27(17):3113-3127. doi: 10.1093/hmg/ddy237.

39.

Primary lateral sclerosis and the amyotrophic lateral sclerosis-frontotemporal dementia spectrum.

Agarwal S, Highton-Williamson E, Caga J, Matamala JM, Dharmadasa T, Howells J, Zoing MC, Shibuya K, Geevasinga N, Vucic S, Hodges JR, Ahmed RM, Kiernan MC.

J Neurol. 2018 Aug;265(8):1819-1828. doi: 10.1007/s00415-018-8917-5. Epub 2018 Jun 4.

PMID:
29868980
40.

Interrogating cortical function with transcranial magnetic stimulation: insights from neurodegenerative disease and stroke.

Agarwal S, Koch G, Hillis AE, Huynh W, Ward NS, Vucic S, Kiernan MC.

J Neurol Neurosurg Psychiatry. 2019 Jan;90(1):47-57. doi: 10.1136/jnnp-2017-317371. Epub 2018 Jun 4. Review.

PMID:
29866706
41.

Reply to: Comment on Y.D. Fragoso et al.: "Lymphocyte count in peripheral blood is not associated with the level of clinical response to treatment with fingolimod" [Mult. Scler. Relat. Disord. (2017)].

Fragoso YD, Spelman T, Boz C, Alroughani R, Lugaresi A, Vucic S, Butzkueven H, Terzi M, Havrdova E, Horakova D, Granella F, Olascoaga J, Menoyo JLS, Pucci E, Barnett M, Brooks JBB, Haartsen J; Lymphopenia and Efficacy of Fingolimod MSBase sub-study Investigators.

Mult Scler Relat Disord. 2018 May;22:166. doi: 10.1016/j.msard.2018.02.025. Epub 2018 Feb 24. No abstract available.

PMID:
29807821
42.

Physiological Processes Underlying Short Interval Intracortical Facilitation in the Human Motor Cortex.

Van den Bos MAJ, Menon P, Howells J, Geevasinga N, Kiernan MC, Vucic S.

Front Neurosci. 2018 Apr 11;12:240. doi: 10.3389/fnins.2018.00240. eCollection 2018.

43.

Role Of spinal mechanisms in the pathophysiology of the split hand sign in amyotrophic lateral sclerosis.

Geevasinga N, Vucic S.

Muscle Nerve. 2018 Oct;58(4):470-471. doi: 10.1002/mus.26139. Epub 2018 May 17. No abstract available.

PMID:
29637578
44.

Physiological changes in neurodegeneration - mechanistic insights and clinical utility.

Ahmed RM, Ke YD, Vucic S, Ittner LM, Seeley W, Hodges JR, Piguet O, Halliday G, Kiernan MC.

Nat Rev Neurol. 2018 May;14(5):259-271. doi: 10.1038/nrneurol.2018.23. Epub 2018 Mar 23. Review.

PMID:
29569624
45.

Ectopic impulse generation in peripheral nerve hyperexcitability syndromes and amyotrophic lateral sclerosis.

Noto YI, Simon NG, Selby A, Garg N, Shibuya K, Shahrizaila N, Huynh W, Matamala JM, Dharmadasa T, Park SB, Vucic S, Kiernan MC.

Clin Neurophysiol. 2018 May;129(5):974-980. doi: 10.1016/j.clinph.2018.01.061. Epub 2018 Feb 10.

PMID:
29554580
46.

Association of Regulatory T-Cell Expansion With Progression of Amyotrophic Lateral Sclerosis: A Study of Humans and a Transgenic Mouse Model.

Sheean RK, McKay FC, Cretney E, Bye CR, Perera ND, Tomas D, Weston RA, Scheller KJ, Djouma E, Menon P, Schibeci SD, Marmash N, Yerbury JJ, Nutt SL, Booth DR, Stewart GJ, Kiernan MC, Vucic S, Turner BJ.

JAMA Neurol. 2018 Jun 1;75(6):681-689. doi: 10.1001/jamaneurol.2018.0035.

47.

Inter-session reliability of short-interval intracortical inhibition measured by threshold tracking TMS.

Matamala JM, Howells J, Dharmadasa T, Trinh T, Ma Y, Lera L, Vucic S, Burke D, Kiernan MC.

Neurosci Lett. 2018 May 1;674:18-23. doi: 10.1016/j.neulet.2018.02.065. Epub 2018 Mar 1.

PMID:
29501687
48.

Rare and Common Variants Conferring Risk of Tooth Agenesis.

Jonsson L, Magnusson TE, Thordarson A, Jonsson T, Geller F, Feenstra B, Melbye M, Nohr EA, Vucic S, Dhamo B, Rivadeneira F, Ongkosuwito EM, Wolvius EB, Leslie EJ, Marazita ML, Howe BJ, Moreno Uribe LM, Alonso I, Santos M, Pinho T, Jonsson R, Audolfsson G, Gudmundsson L, Nawaz MS, Olafsson S, Gustafsson O, Ingason A, Unnsteinsdottir U, Bjornsdottir G, Walters GB, Zervas M, Oddsson A, Gudbjartsson DF, Steinberg S, Stefansson H, Stefansson K.

J Dent Res. 2018 May;97(5):515-522. doi: 10.1177/0022034517750109. Epub 2018 Jan 24.

49.

Lymphocyte count in peripheral blood is not associated with the level of clinical response to treatment with fingolimod.

Fragoso YD, Spelman T, Boz C, Alroughani R, Lugaresi A, Vucic S, Butzkueven H, Terzi M, Havrdova E, Horakova D, Granella F, Olascoaga J, Sánchez-Menoyo JL, Pucci E, Barnett M, Brooks JBB, Haartsen J; Lymphopenia and Efficacy of Fingolimod MSBase sub-study Investigators.

Mult Scler Relat Disord. 2018 Jan;19:105-108. doi: 10.1016/j.msard.2017.11.018. Epub 2017 Nov 22.

PMID:
29182993
50.

Dysphagia in Multiple Sclerosis: Evaluation and Validation of the DYMUS Questionnaire.

Alali D, Ballard K, Vucic S, Bogaardt H.

Dysphagia. 2018 Jun;33(3):273-281. doi: 10.1007/s00455-017-9864-5. Epub 2017 Nov 17. Review.

PMID:
29147920

Supplemental Content

Support Center